NSCLC

Non-small cell lung cancer (NSCLC).

Other Topics:

ATM

(2)
BRCA

(2)
Breast Cancer

(2)
cardiovascular

(1)
CDK12

(2)
CoC

(1)
EGFR

(8)
endocrinology

(1)
Exon 19 Deletion

(4)
Gastric Cancer

(3)
gastroenterology

(1)
immunotherapy

(5)
irAE

(5)
KIT Exon 11

(2)
Lung Cancer

(10)
NSCLC

(9)
Ovarian Cancer

(3)
Prostate Cancer

(2)
rheumatology

(1)
TP53

(2)

Optimizing Frontline Immunotherapy in Advanced Non-Small Cell Lung Cancer

Topics — NSCLC

May 12, 2022 | CME

Quality Improvement Program Webinar—NSCLC Biomarker Testing

Topics — NSCLC

Mar 8, 2022 | Education

Molecular Testing in the Community Oncology Setting

Topics — Breast Cancer, Gastric Cancer, Lung Cancer, NSCLC

Jun 1, 2021 | CME

NCCN updates: Stage IB – IIA NSCLC with EGFR Alteration Patients

Topics — EGFR, Exon 19 Deletion, Lung Cancer, NSCLC

Mar 1, 2021 | Education

NSCLC Patient and Adjuvant Chemotherapy

Topics — EGFR, Lung Cancer, NSCLC

Mar 1, 2021 | Education

Patient with Possible Synchronous Early-stage NSCLC and Different DetermaRx Results

Topics — Lung Cancer, NSCLC

Feb 1, 2021 | Education

Patient with NSCLC Who Recurred within a Year

Topics — EGFR, Lung Cancer, NSCLC

Feb 1, 2021 | Education

Patient with Stage IB NSCLC, an Oncocyte DetermaRx High-Risk Result and an EGFR Exon 19 Deletion

Topics — EGFR, Exon 19 Deletion, Lung Cancer, NSCLC

Feb 1, 2021 | Education

Stratification of Early-Stage, Non-squamous NSCLC Patients Likely to Benefit from Early, Post-operative Chemotherapy

Topics — EGFR, Exon 19 Deletion, Lung Cancer, NSCLC

Feb 1, 2021 | Education

© 2017- OncoLens | All Rights Reserved